Seeking AlphaInvesting Immutep to earn £4M milestone payment from GSKSeeking Alpha - Mamta Mayani Immutep (NASDAQ:IMMP) will receive a milestone payment from GlaxoSmithKline (NYSE:GSK) of £4M (~US$5.02M) related to the first patient being dosed in …
Greece BoG chief to testify in probe into Novartis case meddlingekathimerini.com - info@kathimerini.gr With a special parliamentary committee to be set up in the coming days to investigate the possible mishandling of the Novartis bribery probe, a …
Greece Ex corruption prosecutor to give crucial testimony in Novartis probeekathimerini.com - info@kathimerini.gr Greece's former corruption prosecutor Eleni Raikou, who quit her post in 2017 over alleged political interference in the Novartis bribery …
Gene Therapy Pharmalittle: More countries restrict heartburn meds; Novartis battles Belgium over gene therapy for a toddlerstatnews.com - Ed Silverman • Daily reporting and analysis • The most comprehensive industry coverage from a powerhouse team of reporters• Subscriber-only newsletters • Daily newsletters …
Greece Former corruption prosecutor accuses Papangelopoulos of interventionekathimerini.com - Ioanna Mandrou Greece's former corruption prosecutor Eleni Raikou, who quit her post in 2017 over alleged political interference in the Novartis bribery …
CBS Newsadded this to MoneyWatchFDA More blood-pressure pills recalled over cancer-causing chemicalCBS News - Kate Gibson Torrent Pharmaceuticals is expanding a recall of blood-pressure medication possibly tainted with a cancer-causing chemical. The expansion is the …
Belgium Belgium’s plea for sick toddler denied by pharmaceutical giant Novartisbrusselstimes.com - www.brusselstimes.com A remarkable crowdfunding effort for a Belgian toddler suffering from a life-threatening genetic disease has seen one of the world’s largest …
Medicine Novel Drug Impresses in Postpartum Depression Phase 3 Trialmedscape.com - www.medscape.com COPENHAGEN, Denmark — Results of a phase 3 trial show the novel drug SAGE-217 (Zuranolone, Sage Therapeutics) for postpartum depression (PPD) was …
FOX BusinessRanitidine Zantac generic shipments halted by Novartis over cancer fearsFOX Business - Christian de La ChapelleSandoz, a unit of Switzerland-based pharmaceutical giant Novartis, halted the distribution of generic versions of its heartburn medication Zantac, in the wake of the U.S Food and Drug Administration's
Peak Bggradded this to Marijuana InvestingCannabis This Opioid Producer Just Said Yes to CannabisThe Motley Fool - Sean Williams In the years to come, marijuana could very well be one of the fastest-growing industries on the planet. According to a slew of Wall Street …
CNNadded this to Top StoriesRanitidine Drugmaker halts shipments of ranitidine heartburn medication after contaminant foundCNN - By Katie Hunt, CNN(CNN) — Drugmaker Novartis said it is halting distribution of all ranitidine medicines made by Sandoz, a measure it called "precautionary" after the acid-reducing medications were found to contain an The
Seeking Alphaadded this to Breaking NewsInvesting European advisory groups backs expanded use of LucentisSeeking Alpha - Douglas W. House The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Novartis Europharm Limited's (NYSE:NVS) …
The Hindu Groupadded this to BusinessLineZantac Europe, Canada start recall of Zantac drug versions after carcinogen scarethehindubusinessline.com - Bloomberg Drugmakers and global public-health regulators are taking steps to remove supplies of a popular heartburn medication that may have become tainted …
Greece Parliament body to decide on fate of Novartis probeekathimerini.com - Aristotelia Peloni It remained unclear on Thursday whether the special Parliament committee which will be set up in early October to probe the possible mishandling of …
U.S. Politics Daily on Healthcare: Pelosi unveils drug pricing planwashingtonexaminer.com - Kimberly Leonard Subscribe today to the Washington Examiner magazine and get Washington Briefing: politics and policy stories that will keep you up to date with what's …
Blakeadded this to To ListenAmgen Listen: Unicorn growth spurts, Amgen’s future, & mice on Twitterstatnews.com - Damian Garde Who puts horns on unicorns? How do graying drug companies find green ideas? And what would mice tweet? We discuss all that and more on the latest …
USA TODAYadded this to Top StoriesZantac Cancer worries halt shipments of generic ZantacUSA TODAY Money - Nathan BomeyA division of Swiss pharmaceutical maker Novartis is halting distribution of generic Zantac pills over concerns about an ingredient possibly linked to cancer. Novartis-owned Sandoz has issued a "precautionary
NBC Newsadded this to HealthZantac Novartis halts distribution of Zantac heartburn medication due to contaminantNBC News - ReutersMedication already in stores will still be available as FDA reviews safety of ingredient linked to increase in cancer risk. Novartis AG's Sandoz unit said on Wednesday it was halting distribution of its
Audioburstadded this to Audioburst US NewsZantac Listen: Novartis has halted distribution of generic Zantac. Here's what you need to know.Audioburst - KQED Radio "The drug company Novartis's holding the distribution of popular heartburn medicines that were found to be contaminated with a probable carcinogen …
CBS Newsadded this to MoneyWatchZantac Zantac maker halts heartburn drug's distribution after FDA raises cancer concernsCBS News - Sarah Min The maker of the popular heartburn medication Zantac said Wednesday it has stopped distributing the drug worldwide pending investigations from U.S. …
The Daily BeastZantac Novartis Halts Distribution of Generic Zantac Amid FDA ProbeThe Daily Beast - Summer Eldemire The Sandoz division of pharmaceutical company Novartis AG announced it is halting global distribution of its generic versions of the heartburn …
Reutersadded this to Health & LifestyleGene Therapy British baby's death not due to SMA gene therapy: NovartisReuters - By John MillerZURICH (Reuters) - A British baby's death this year after getting Novartis's gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient
Audioburstadded this to Audioburst Health & Science NewsZantac Listen: FDA warns of cancer-causing impurity in popular heartburn drug ZantacAudioburst - WCBS Newsradio 880 "For the maker of a popular heartburn drugs says it's stopping distribution after tests revealed it contained a likely cancer causing substance CBS …
The Washington Postadded this to BusinessBusiness Business Digest: Distribution of generic Zantac is halted over contaminantsThe Washington PostNovartis AG’s Sandoz unit said Wednesday it was halting distribution of its versions of the drug Zantac in all its markets, including the United States and Canada, after contaminants were found in the
U.S. Food and Drug Administration Belgian family hits fundraising target for world’s priciest drugpolitico.eu - Carmen Paun The family of a 9-month-old Belgian infant, Pia Boehnke, has raised almost €2 million in three days to pay for the spinal muscular atrophy drug …
CBS Newsadded this to CBS NewsZantac Novartis halts distribution of generic heartburn medicationCBS News The maker of a generic version of Zantac is halting distribution. It comes after an FDA warning about a possible cancer-causing chemical found in …
Investing.com Canadaadded this to Canada NewsQuébec BRIEF-Novartis Pharmaceuticals Canada Says Quebec To Reimburse KISQALIinvesting.com - Reuters * NOVARTIS PHARMACEUTICALS CANADA - QUEBEC TO REIMBURSE KISQALI FOR ELIGIBLE PATIENTS IN COMBINATION WITH LETROZOLE FOR TREATING METASTATIC BREAST …
Peak Bggradded this to Biotech InvestingGene Therapy Novartis SMA gene therapy shows sustained benefit in late-stage studiesSeeking Alpha - Douglas W. House Novartis (NYSE:NVS) unit AveXis announces updated data from the Phase 3 SPR1NT and STR1VE studies evaluating gene therapy Zolgensma (onasemnogene …
Seeking AlphaPharma New president at CASI PharmaSeeking Alpha - Mamta Mayani Mr. Zhang first joined CASI in September 2018 as President of CASI Pharma (Beijing), its China operating subsidiary. Prior to joining CASI's Beijing …
Stocks Novartis Announces New Data on Spondylitis Drug Cosentyxyahoo.com - Zacks Equity Research Swiss pharma giant Novartis AG NVS announced positive new data from the ongoing PREVENT study on spondylitis drug, Cosentyx (secukinumab). PREVENT is …
